IntelGenx to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference

Rhea-AI Summary

IntelGenx Technologies Corp. (TSX:IGX, OTCQB:IGXT) will present a business update at the Bloom Burton & Co. Healthcare Investor Conference on May 3, 2022, at 9:30 a.m. ET, located at the Metro Toronto Convention Centre. The presentation will also be live-streamed and archived on the company's website under the Investors section. IntelGenx specializes in developing pharmaceutical films using advanced technologies such as VersaFilm®, DisinteQ™, VetaFilm™, and VevaDerm™. The company focuses on addressing unmet medical needs with its innovative product pipeline.

SAINT LAURENT, Quebec, April 26, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that management will present an update on the Company’s business at the Bloom Burton & Co. Healthcare Investor Conference on Tuesday, May 3, 2022 at 9:30 a.m. Eastern Time at the Metro Toronto Convention Centre.

The presentation will be broadcast live and archived on the Company's website at www.intelgenx.com under "Webcasts" in the Investors section.

About IntelGenx

IntelGenx is a leading drug delivery company focused on the development and manufacturing of pharmaceutical films.

IntelGenx’s superior film technologies, including VersaFilm^®, DisinteQ^™, VetaFilm^™ and transdermal VevaDerm^™, allow for next generation pharmaceutical products that address unmet medical needs. IntelGenx’s innovative product pipeline offers significant benefits to patients and physicians for many therapeutic conditions.

IntelGenx's highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. IntelGenx's state-of-the-art manufacturing facility offers full service by providing lab-scale to pilot- and commercial-scale production. For more information, visit www.intelgenx.com.

Forward-Looking Information and Statements

This document may contain forward-looking information about IntelGenx's operating results and business prospects that involve substantial risks and uncertainties. Statements that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These statements include, but are not limited to, statements about IntelGenx's plans, objectives, expectations, strategies, intentions or other characterizations of future events or circumstances and are generally identified by the words "may," "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "could," "would," and similar expressions. All forward looking statements are expressly qualified in their entirety by this cautionary statement. Because these forward-looking statements are subject to a number of risks and uncertainties, IntelGenx's actual results could differ materially from those expressed or implied by these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed under the heading "Risk Factors" in IntelGenx's annual report on Form 10-K, filed with the United States Securities and Exchange Commission and available at www.sec.gov, and also filed with Canadian securities regulatory authorities at www.sedar.com. IntelGenx assumes no obligation to update any such forward-looking statements.

Source: IntelGenx Technologies Corp.

For IntelGenx:

Stephen Kilmer
Investor Relations
(647) 872-4849
stephen@kilmerlucas.com

Or

Andre Godin, CPA, CA
President and CFO
IntelGenx Corp.
(514) 331-7440 ext 203
andre@intelgenx.com

FAQ

When will IntelGenx present at the Bloom Burton & Co. Healthcare Investor Conference?

IntelGenx will present on May 3, 2022, at 9:30 a.m. Eastern Time.

Where is the Bloom Burton & Co. Healthcare Investor Conference being held?

The conference will be held at the Metro Toronto Convention Centre.

How can I watch IntelGenx's presentation at the conference?

You can watch IntelGenx's presentation live and archived on their website under the Investors section.

What technologies does IntelGenx use in its pharmaceutical films?

IntelGenx uses technologies such as VersaFilm®, DisinteQ™, VetaFilm™, and VevaDerm™.

What is IntelGenx's focus in the pharmaceutical industry?

IntelGenx focuses on developing and manufacturing pharmaceutical films that address unmet medical needs.